Company / R&D per Share
Align Technology R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$5.18
FY2025
5-year range
$3.18 / $5.18
FY2021-FY2025
Trend
+5.1%
vs FY2024
Sector context
#6 of 108
Health Care
What the data says
Among 108 Health Care companies, Align Technology is in the top 6% for r&d per share. R&D per Share has increased for 9 consecutive years, from $0.95 in FY2016 to $5.18 in FY2025.
Based on SEC 10-K filings.
5.18 in FY2025 with a 5-year CAGR of +18.5%. Top quartile in the Health Care sector.
Improved from $4.62 to $5.18 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +9.5%
- 5-Year CAGR
- +18.5%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 108This company $5.18 Sector average $2.07
▼
+150.4% above sector average
Key checks
Key Insights
- Align Technology's r&d per share has grown for 9 consecutive years.
- In FY2025, r&d per share increased 5.1% year-over-year.
- Ranks #6 out of 108 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.18 | +5.1% |
| FY2024 | $4.93 | +6.8% |
| FY2023 | $4.62 | +16.9% |
| FY2022 | $3.95 | +24.2% |
| FY2021 | $3.18 | +43.1% |
| FY2020 | $2.22 | +10.8% |
| FY2019 | $2.01 | +24.2% |
| FY2018 | $1.62 | +31.8% |
| FY2017 | $1.23 | +28.8% |
| FY2016 | $0.95 | +23.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026